» Articles » PMID: 38205003

Increased Cardiac Risk After a Second Malignant Neoplasm Among Childhood Cancer Survivors: A FCCSS Study

Abstract

Background: Childhood cancer survivors (CCS) are at an elevated risk of developing both a second malignant neoplasm (SMN) and cardiac disease.

Objectives: This study sought to assess the excess of occurrence of cardiac disease after a SMN among CCS.

Methods: Analyses included 7,670 CCS from the French Childhood Cancer Survivors Study cohort diagnosed between 1945 and 2000. To account for the time dependence of the occurrence of a SMN, we employed a landmark approach, considering an additive regression model for the cumulative incidence of cardiac disease. We estimated the effect of a SMN on the instantaneous risk of cardiac disease using a proportional cause-specific hazard model, considering a SMN as a time-dependent exposure. In both models, we adjusted for demographic and treatment information and considered death as a competing event.

Results: In 7,670 CCS over a median follow-up of 30 years (IQR: 22-38 years), there were 378 cases of cardiac disease identified, of which 49 patients experienced a SMN. Patients who survived 25 years after their childhood cancer diagnosis and had a SMN in that time frame had a significantly increased cumulative incidence of cardiac disease, which was 3.8% (95% CI: 0.5% to 7.1%) higher compared with those without a SMN during this period. No SMN-induced excess of cardiac disease was observed at subsequent landmark times. SMNs were associated with a 2-fold increase (cause-specific HR: 2.0; 95% CI: 1.4-2.8) of cardiac disease.

Conclusions: The occurrence of a SMN among CCS is associated with an increased risk of cardiac disease occurrence and risk at younger ages.

Citing Articles

Second Malignancies and Cardiovascular Disease in Childhood Cancer Survivors: Double Trouble.

Narayan H, Narezkina A, Ehrhardt M JACC CardioOncol. 2024; 5(6):804-806.

PMID: 38205004 PMC: 10774780. DOI: 10.1016/j.jaccao.2023.08.005.

References
1.
Chow E, Chen Y, Hudson M, Feijen E, Kremer L, Border W . Prediction of Ischemic Heart Disease and Stroke in Survivors of Childhood Cancer. J Clin Oncol. 2017; 36(1):44-52. PMC: 5756324. DOI: 10.1200/JCO.2017.74.8673. View

2.
ANDERSON J, Cain K, Gelber R . Analysis of survival by tumor response. J Clin Oncol. 1983; 1(11):710-9. DOI: 10.1200/JCO.1983.1.11.710. View

3.
Chow E, Chen Y, Kremer L, Breslow N, Hudson M, Armstrong G . Individual prediction of heart failure among childhood cancer survivors. J Clin Oncol. 2014; 33(5):394-402. PMC: 4314592. DOI: 10.1200/JCO.2014.56.1373. View

4.
Lipshultz S, Adams M, Colan S, Constine L, Herman E, Hsu D . Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation. 2013; 128(17):1927-95. DOI: 10.1161/CIR.0b013e3182a88099. View

5.
Moskowitz C, Chou J, Neglia J, Partridge A, Howell R, Diller L . Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2019; 37(24):2120-2130. PMC: 6698921. DOI: 10.1200/JCO.18.02219. View